HER2 breast cancer is one of the most frequently occurring types of cancer worldwide, and one of the potential biomarkers for its detection could be human epidermal growth factor receptors (HER/erbB), which is involved in normal growth and differentiation. The gene discussed is ERBB2; the disease is breast carcinoma.